Institute of Medicine elects four new members from Penn

Four professors from Penn’s School of Medicine have been elected to the Institute of Medicine (IOM), one of the nation’s highest honors in biomedicine. Established in 1970 by the National Academy of Sciences, IOM recognizes professional achievement in the health sciences and serves as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences, and health.

The new Penn members are: Deborah A. Driscoll, the Luigi Mastroianni, Jr. Professor and chair of the Department of Obstetrics and Gynecology; Caryn Lerman, the Mary W. Calkins Professor in the Department of Psychiatry and the Annenberg Public Policy Center; John R. Stanley, the Milton B. Hartzell Professor and chair of the Department of Dermatology; and Margaret Stineman, professor of Physical Medicine and Rehabilitation and professor of Epidemiology in the Center for Clinical Epidemiology and Biostatistics. The active IOM membership numbers 1,649 and the new inductees brings the number of Penn's representatives to 76.

“We are proud that four of our most distinguished and accomplished scientists have been named to one of the country's leading institutions,” says Arthur H. Rubenstein, executive vice president of the University of Pennsylvania for the Health System and dean of the School of Medicine. “Having Penn Medicine colleagues elected to this esteemed body is an extraordinarily significant honor.”

Penn Current Express

Quoted Recently

“More companies are asking how they can separate themselves from the organization and instead tighten their connection to the game. The brand of FIFA is problematic but the game of soccer is still popular.”

— Kenneth L. Shropshire, director of the Wharton Sports Business Initiative, on how the FIFA corruption scandal has caused some sponsors to be less concerned about partnering with the powerful soccer organization. FIFA tends to have the most leverage when negotiating deals with companies, but experts are wondering whether sponsors will be able to demand clauses that allow them to leave in cases of corruption. (The Los Angeles Times, June 3, 2015)